Clinical outcomes of resected EGFR positive stage I-III NSCLC patients in the Midlands, UK

被引:0
|
作者
Powell, R. L. [1 ]
Murukesh, N. [2 ]
Seeva, P. [2 ]
Solanki, A. [3 ]
Singh, A. [3 ]
Jain, A. [4 ]
Elmasry, A. R. [5 ]
Jegannathen, A. [5 ]
Irwin, A. [6 ]
Ghafoor, Q. [6 ]
O'Sullivan, B. [6 ]
Taniere, P. [7 ]
Baijal, S. [8 ]
机构
[1] Univ Hosp Birmingham NHS Fdn Trust, Clin Haematol & Oncol Dept, Heartlands Hosp, Birmingham, W Midlands, England
[2] Worcestershire Royal Hosp, Dept Oncol, Worcester, England
[3] Royal Wolverhampton NHS Trust, New Cross Hosp, Deanesly Ctr, Wolverhampton, England
[4] New Cross Hosp, Royal Wolverhampton Hosp NHS Trust, Wolverhampton, England
[5] Univ Hosp North Midlands, Stoke On Trent, Staffs, England
[6] New Queen Elizabeth Hosp Birmingham, Oncol, Birmingham, W Midlands, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England
[8] Heart England NHS Fdn Trust, Heartlands Hosp, Birmingham, W Midlands, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
67P
引用
收藏
页码:S731 / S732
页数:2
相关论文
共 50 条
  • [41] CTL ANTIGEN 4 (CTLA-4) AND KI67 AS PROGNOSTIC FACTORS IN RESECTED STAGE I-III NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Rijavec, E.
    Dal Bello, M. G.
    Sini, C.
    Genova, C.
    Barletta, G.
    Laurent, S.
    Truini, M.
    Pistillo, M. P.
    Merlo, D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S35 - S35
  • [42] Ribonucleotide reductase subunit 2 (RRM2) to predict shorter survival in resected stage I-III non-small cell lung cancer (NSCLC) patients.
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Savarino, Graziana
    Sini, Claudio
    Barletta, Giulia
    Genova, Carlo
    Truini, Mauro
    Pronzato, Paolo
    Merlo, Domenico Franco
    Pfeffer, Ulrich
    Grossi, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] The Impact of EGFR Mutations on the Prognosis of Patients with Resected Stage I Lung Adenocarcinoma
    Kitamura, Jiro
    Tapias, Luis
    Mathisen, Douglas
    Lanuti, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S620 - S621
  • [44] Pattern of Postoperative Recurrence and Clinical Value of Adjuvant Radiotherapy in Completely Resected Stage III/N2 EGFR-Mutant NSCLC
    Ni, J.
    Guo, T.
    Li, Y.
    Zhu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1098 - S1098
  • [45] Clinical Outcomes of Concurrent Chemoradiation vs RT alone in Elderly Patients with Stage III NSCLC
    Kim, D. Y.
    Kim, J.
    Song, C.
    Lee, J. S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S397 - S397
  • [46] CD34+ and SMA+ cancer-associated fibroblasts influence prognosis in stage I-III NSCLC patients
    Schulze, A. B.
    Schmidt, L. H.
    Heitkoetter, B.
    Huss, S.
    Mohr, M.
    Marra, A.
    Hillejan, L.
    Goerlich, D.
    Barth, P. J.
    Rehkaemper, J.
    Evers, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 144 - 144
  • [47] OUTCOMES FROM A SINGLE INSTITUTION COHORT OF 248 PATIENTS WITH STAGE I-III ESOPHAGEAL CANCER TREATED WITH RADIOTHERAPY
    Lavergne, Carrie
    Niglas, Mark
    Fulton, Abrielle
    Youssef, Andrew
    Fathima, Ayesha
    Youssef, Youssef
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S27 - S27
  • [48] Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC
    Gallina, Filippo Tommaso
    Marinelli, Daniele
    Taje, Riccardo
    Forcella, Daniele
    Alessandrini, Gabriele
    Cecere, Fabiana Letizia
    Fusco, Francesca
    Visca, Paolo
    Sperduti, Isabella
    Ambrogi, Vincenzo
    Cappuzzo, Federico
    Melis, Enrico
    Facciolo, Francesco
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] Adjuvant treatment following irradical resection of stage I-III NSCLC: a population-based study
    Rasing, M.
    Peters, M.
    Aarts, M.
    Herder, G.
    van Lindert, A.
    Schramel, F.
    van der Meer, F.
    Verhoeff, J.
    van Rossum, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S117 - S118
  • [50] Comparison of Mini Laparotomy with Conventional Laparotomy as the Surgical Approach in Stage I-III CRC Patients: Appealing Outcomes
    Tsai, Hsiang-Lin
    Chen, Ming-Jenn
    Yeh, Yung-Sung
    Chen, Chao-Wen
    Sun, Li-Chu
    Lu, Chien-Yu
    Yang, I-Ping
    Wang, Jaw-Yuan
    HEPATO-GASTROENTEROLOGY, 2012, 59 (119) : 2132 - 2136